Agenus to host “the road taken” r&d event on november 12, 2022

Lexington, mass., oct. 05, 2022 (globe newswire) -- agenus (nasdaq: agen), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced it will host an in-person and virtual research & development event (“the road taken”) on saturday, november 12, 2022, from 2:00 p.m. to 5:00 p.m. et at the prudential tower in boston, ma.
AGEN Ratings Summary
AGEN Quant Ranking